Protalix Biotherapeutics Inc
0 sources
Financials
0001104659-26-029858Protalix Biotherapeutics Inc
Summary
Protalix Biotherapeutics Inc is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (30 views/month).[2]
Key Facts
- Protalix Biotherapeutics Inc is in the country of Israel[3].
- Protalix Biotherapeutics Inc is in the country of US[4].
- Protalix Biotherapeutics Inc's instance of is recorded as business[5].
- Protalix Biotherapeutics Inc's instance of is recorded as public company[6].
- Protalix Biotherapeutics Inc's founder is recorded as Joseph Chaaltiel[7].
- Protalix Biotherapeutics Inc's headquarters location is recorded as Karmiel[8].
- Protalix Biotherapeutics Inc's stock exchange is recorded as NYSE American[9].
- Protalix Biotherapeutics Inc's stock exchange is recorded as Tel Aviv Stock Exchange[10].
- Protalix Biotherapeutics Inc's stock exchange is recorded as Tel Aviv Stock Exchange[11].
- Protalix Biotherapeutics Inc's industry is recorded as biotechnology[12].
- 1993 marks the founding of Protalix Biotherapeutics Inc[13].
- Protalix Biotherapeutics Inc's location of formation is recorded as United States[14].
- Protalix Biotherapeutics Inc's official website is recorded as http://www.protalix.com/[15].
- Protalix Biotherapeutics Inc's official website is recorded as https://www.protalix.com[16].
- Protalix Biotherapeutics Inc's email address is recorded as mailto:[email protected][17].
- Protalix Biotherapeutics Inc's product or material produced is recorded as taliglucerase alfa[18].
- Protalix Biotherapeutics Inc's phone number is recorded as +972-4-9889488[19].
- Protalix Biotherapeutics Inc's official name is recorded as {'lang': 'he', 'text': "פרוטליקס ביות'רפיוטיקס אינק"}[20].
- Protalix Biotherapeutics Inc's legal form is recorded as limited company[21].
- Protalix Biotherapeutics Inc's legal form is recorded as XTIQ[22].
- Protalix Biotherapeutics Inc's market capitalization is recorded as {'unit': 'Q131309', 'amount': '+178814000'}[23].
- Protalix Biotherapeutics Inc's fax number is recorded as +972-4-9889489[24].
- Protalix Biotherapeutics Inc's street address is recorded as {'lang': 'he', 'text': 'סנונית 2, כרמיאל'}[25].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 549300SDVB3GP4XDFM60[26]
-
Registered legal name: Protalix BioTherapeutics, Inc.[27]
-
Legal jurisdiction: US-DE[28]
-
GLEIF entity category: GENERAL[29]
-
Legal form (ISO 20275 ELF): XTIQ[30]
-
Entity status: ACTIVE[31]
-
LEI registration status: LAPSED[32]
-
LEI first registered: 2016-11-30[33]
-
LEI last updated: 2023-08-04[34]
-
LEI next renewal: 2017-11-28[35]
-
Managing LOU: 5493001KJTIIGC8Y1R12[36]
-
Registration authority: RA999999[37]
-
Other names: Orthodontix, Inc.[38]
-
Conformity flag: NON_CONFORMING[39]
Body
Founding
Protalix Biotherapeutics Inc's founder is recorded as Joseph Chaaltiel[7]. 1993 marks the founding of it[13]. Its location of formation is recorded as United States[14].
Identity
Protalix Biotherapeutics Inc's official name is recorded as {'lang': 'he', 'text': "פרוטליקס ביות'רפיוטיקס אינק"}[20].
Operations
Protalix Biotherapeutics Inc's headquarters location is recorded as Karmiel[8].
Industry
Protalix Biotherapeutics Inc's industry is recorded as biotechnology[12].
Ownership
Stock exchanges include NYSE American[9] and Tel Aviv Stock Exchange[10]. Protalix Biotherapeutics Inc's product or material produced is recorded as taliglucerase alfa[18].
Why It Matters
Protalix Biotherapeutics Inc ranks in the top 4% of business entities by monthly Wikipedia readership (30 views/month).[2]